Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients
This chapter highlights other histologic features beyond eosinophil count that may be present in patients with EoE.
Hear Dr. Ulrike von Arnim discuss the expert recommendations for monitoring patients with EoE in routine clinical practice.

Join Dr. Kwatra outlining the micro itch cycle involving type 2 cell polarization and cytokines that directly affect fibroblasts to cause more immune dysregulation in PN.

Dr. Jonathan Corren describes the diagnostic, predictive, and prognostic role of IgE as a biomarker of type 2 inflammation in asthma.
Explore the impact of type 2 inflammation and airway remodeling on lung function decline in asthma.
Dr. Evan Dellon highlights how resolution of food impaction can be leveraged as an opportunity to diagnose EoE.

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma.
Dr. Donna Culton focuses on the challenges of diagnosis and the unmet needs for patients with BP
Watch as Leonard Bacharier, MD, and Sharon Dell, MD, FRCPC, discuss the concept of clinical remission in pediatric severe asthma.
Professors Celeste Porsbjerg and Klaus Rabe and Dr Mario Castro discuss the pathophysiology of airway remodeling and its impact on patients with severe asthma.